Tulobuterol transdermal patch and method for preparing the same
By optimizing the composition and preparation process of tuloterol transdermal patches, the problems of uneven drug crystallization and insufficient adhesion were solved, achieving consistent transdermal effects and product stability, while reducing production costs.
Patent Information
- Application Number
- CN202511978608.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-25
- Publication Date
- 2026-05-01
- Estimated Expiration
- 2045-12-25
AI Technical Summary
Existing tuloterol transdermal patches suffer from problems such as uneven drug crystallization, insufficient adhesion, and unstable processes during preparation, which affect efficacy and safety.
The preparation process is optimized by using pressure-sensitive adhesives, penetration enhancers, tackifiers and stabilizers with specific compositions. This includes selecting acrylic copolymers without functional groups as pressure-sensitive adhesives, using propylene glycol and ethyl oleate as penetration enhancers, adding polyisobutylene as a tackifier, selecting dibutylhydroxytoluene as a stabilizer, and using a bottom plate heating and drying method.
This approach achieves consistent transdermal efficacy and improved adhesion of tuloterrol transdermal patches, reduces drug loss, enhances product stability and quality, and lowers production costs.